NPI: 1386720183 · MARTINSVILLE, VA 24112 · Rural Acute Care Hospital · NPI assigned 10/27/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 10/27/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 79,578 | $2.27M |
| 2019 | 144,275 | $5.09M |
| 2020 | 116,684 | $4.29M |
| 2021 | 142,030 | $5.07M |
| 2022 | 116,013 | $4.37M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 22,738 | 20,039 | $3.68M |
| 96361 | Intravenous infusion, hydration; each additional hour | 13,435 | 10,811 | $3.61M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19,370 | 17,652 | $2.85M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10,133 | 9,132 | $1.69M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,412 | 3,196 | $797K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,460 | 4,116 | $785K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5,480 | 5,132 | $782K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5,362 | 4,276 | $484K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,987 | 1,850 | $449K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,583 | 2,061 | $393K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2,972 | 2,768 | $375K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 576 | 552 | $330K |
| 96367 | 1,530 | 956 | $318K | |
| G0378 | Hospital observation service, per hour | 2,462 | 1,888 | $309K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,315 | 1,558 | $291K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,629 | 3,006 | $266K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 924 | 886 | $257K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1,021 | 966 | $209K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,318 | 1,256 | $200K |
| 80053 | Comprehensive metabolic panel | 31,851 | 25,495 | $194K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,973 | 7,421 | $181K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1,387 | 1,325 | $154K |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,896 | 3,889 | $149K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,923 | 3,708 | $133K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8,114 | 7,086 | $109K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,785 | 1,761 | $106K |
| 10060 | 602 | 547 | $94K | |
| 93970 | 700 | 660 | $87K | |
| 83880 | 6,371 | 5,601 | $75K | |
| 76830 | Ultrasound, transvaginal | 598 | 562 | $68K |
| 71046 | Radiologic examination, chest; 2 views | 2,116 | 1,987 | $68K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,111 | 3,802 | $67K |
| 87040 | 6,768 | 5,323 | $63K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 115 | 107 | $56K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 69 | 68 | $52K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2,549 | 2,485 | $52K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 1,534 | 793 | $48K |
| 84145 | 3,612 | 3,291 | $46K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1,045 | 979 | $42K |
| 36415 | Collection of venous blood by venipuncture | 10,341 | 8,272 | $41K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,226 | 1,142 | $40K |
| 76642 | 334 | 290 | $39K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,046 | 446 | $37K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 278 | 264 | $37K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 59 | 56 | $36K |
| 72100 | 1,927 | 1,803 | $35K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 36,670 | 28,342 | $34K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,460 | 5,086 | $34K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,539 | 4,695 | $34K |
| 29125 | 282 | 268 | $33K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2,376 | 2,231 | $31K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 17,892 | 15,172 | $26K |
| 74018 | 2,127 | 1,952 | $26K | |
| 12001 | 88 | 85 | $24K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 415 | 112 | $23K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 767 | 236 | $22K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,219 | 883 | $21K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 272 | 254 | $20K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,427 | 7,327 | $19K |
| 85379 | 2,483 | 2,321 | $19K | |
| 93017 | 130 | 122 | $18K | |
| 84484 | 11,392 | 9,281 | $16K | |
| 71045 | Radiologic examination, chest; single view | 17,327 | 15,226 | $16K |
| 76770 | 124 | 117 | $15K | |
| 76801 | 196 | 179 | $14K | |
| 85027 | 3,017 | 2,468 | $14K | |
| 97161 | 1,020 | 931 | $13K | |
| 73630 | 1,133 | 1,041 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,930 | 3,624 | $12K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 25 | 25 | $12K |
| 73610 | 1,249 | 1,151 | $12K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 7,176 | 6,441 | $11K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 418 | 412 | $10K |
| 76536 | 70 | 70 | $10K | |
| 97016 | 240 | 68 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,030 | 1,896 | $9K |
| 73030 | 1,083 | 991 | $9K | |
| 59025 | Fetal non-stress test | 62 | 42 | $9K |
| 83605 | 6,101 | 5,307 | $8K | |
| 43235 | 13 | 12 | $8K | |
| 73130 | 1,099 | 993 | $8K | |
| 87081 | 5,555 | 5,235 | $8K | |
| 82607 | 804 | 762 | $8K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 40 | 39 | $8K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2,347 | 2,203 | $8K |
| 82728 | 1,368 | 1,244 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 564 | 537 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,589 | 1,505 | $7K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 1,006 | 841 | $7K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 95 | 83 | $7K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 238 | 108 | $7K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 9,981 | 8,361 | $7K |
| 81001 | 21,901 | 19,060 | $7K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 26 | 24 | $7K |
| 73564 | 347 | 299 | $6K | |
| 73502 | 625 | 564 | $6K | |
| 83735 | 6,333 | 4,548 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 15,080 | 13,173 | $6K |
| 82553 | 1,970 | 1,732 | $6K | |
| 80061 | Lipid panel | 1,475 | 1,386 | $5K |
| 82962 | 6,853 | 4,688 | $5K | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 353 | 332 | $4K |
| 81025 | 3,805 | 3,546 | $4K | |
| 94010 | 87 | 81 | $4K | |
| 83550 | 1,415 | 1,289 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 176 | 169 | $4K |
| 84702 | 1,535 | 1,254 | $4K | |
| 87077 | 2,868 | 2,586 | $4K | |
| 96368 | 767 | 540 | $4K | |
| J2704 | Injection, propofol, 10 mg | 2,984 | 2,822 | $4K |
| 83540 | 1,456 | 1,326 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,400 | 2,242 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 223 | 139 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6,053 | 5,151 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,827 | 3,498 | $3K |
| 97116 | 181 | 104 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 73 | 73 | $3K |
| 73110 | 402 | 369 | $3K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,201 | 2,011 | $3K |
| 90715 | 200 | 198 | $3K | |
| 36600 | 3,401 | 3,008 | $3K | |
| 71250 | 43 | 40 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 14 | 12 | $3K |
| 85610 | 10,291 | 8,975 | $3K | |
| 72050 | 135 | 129 | $3K | |
| 84439 | 445 | 414 | $2K | |
| 0001A | 156 | 155 | $2K | |
| 94726 | 86 | 80 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,832 | 8,572 | $2K |
| 0012A | 76 | 75 | $2K | |
| 73562 | 408 | 369 | $2K | |
| 87070 | 528 | 487 | $2K | |
| 94150 | 87 | 81 | $2K | |
| 94729 | 86 | 80 | $2K | |
| 87210 | 1,393 | 1,310 | $2K | |
| 86850 | 1,084 | 954 | $2K | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 15 | 13 | $2K |
| 70491 | 12 | 12 | $2K | |
| 85652 | 1,261 | 1,098 | $2K | |
| 29515 | 13 | 13 | $2K | |
| 86140 | 498 | 425 | $2K | |
| J1815 | Injection, insulin, per 5 units | 1,409 | 1,060 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,429 | 7,559 | $2K |
| 77066 | Tomosynthesis, mammo | 69 | 67 | $2K |
| 82805 | 3,593 | 3,169 | $2K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13 | 12 | $2K |
| 87186 | 2,914 | 2,624 | $1K | |
| 90714 | 103 | 100 | $1K | |
| 86900 | 1,515 | 1,340 | $1K | |
| 70486 | 28 | 26 | $1K | |
| 82550 | 6,379 | 5,594 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | 42 | 26 | $1K |
| 71271 | 13 | 13 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 467 | 289 | $1K |
| 0011A | 79 | 77 | $1K | |
| 72070 | 53 | 51 | $1K | |
| 83615 | 664 | 564 | $1K | |
| 82746 | 253 | 238 | $983.63 | |
| 72040 | 26 | 25 | $943.75 | |
| 74019 | 41 | 37 | $941.09 | |
| 76870 | 15 | 12 | $887.93 | |
| 86618 | 82 | 58 | $859.79 | |
| 86901 | 1,514 | 1,340 | $831.93 | |
| 73590 | 116 | 106 | $806.88 | |
| 93971 | 13 | 13 | $798.82 | |
| 82565 | 177 | 168 | $735.86 | |
| 0002A | 25 | 24 | $734.68 | |
| 83690 | 8,456 | 7,449 | $728.23 | |
| 84703 | 4,796 | 4,372 | $713.16 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,416 | 1,215 | $674.57 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 307 | 103 | $670.30 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 13 | 13 | $654.26 |
| 85730 | 8,906 | 7,894 | $632.64 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,463 | 2,197 | $618.04 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,733 | 1,491 | $604.88 |
| 87428 | 956 | 878 | $601.70 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,388 | 1,308 | $591.34 |
| J3480 | Injection, potassium chloride, per 2 meq | 912 | 612 | $576.08 |
| 73560 | 64 | 52 | $526.59 | |
| 73080 | 95 | 92 | $526.13 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5,481 | 5,192 | $515.61 |
| 86300 | 29 | 25 | $498.69 | |
| 84100 | 760 | 580 | $482.94 | |
| 82784 | 123 | 89 | $480.07 | |
| 51702 | 31 | 24 | $471.27 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,842 | 1,503 | $456.04 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,419 | 1,932 | $423.01 |
| 77065 | Tomosynthesis, mammo | 14 | 13 | $417.64 |
| 86003 | 65 | 51 | $402.80 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,501 | 1,392 | $350.33 |
| C9113 | Injection, pantoprazole sodium, per vial | 2,667 | 2,262 | $335.67 |
| 87807 | 1,353 | 1,284 | $331.74 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,673 | 3,023 | $323.21 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 85 | 81 | $284.61 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,006 | 2,502 | $268.79 |
| 86757 | 38 | 28 | $239.84 | |
| 80164 | 27 | 24 | $236.10 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 15 | 15 | $234.13 |
| 82570 | 48 | 44 | $205.80 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,256 | 2,862 | $194.91 |
| 88342 | 109 | 97 | $192.54 | |
| 73090 | 53 | 50 | $190.37 | |
| 88304 | 347 | 324 | $187.19 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 1,151 | 989 | $186.13 |
| 82274 | 481 | 446 | $173.16 | |
| 80178 | 14 | 13 | $150.84 | |
| 86803 | 14 | 14 | $150.47 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,720 | 1,450 | $148.89 |
| 73552 | 32 | 26 | $144.11 | |
| J2060 | Injection, lorazepam, 2 mg | 1,359 | 1,171 | $135.91 |
| J1644 | Injection, heparin sodium, per 1000 units | 547 | 283 | $131.53 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 118 | 112 | $125.71 |
| 87205 | 321 | 292 | $119.20 | |
| 96376 | 2,450 | 1,799 | $118.74 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,139 | 978 | $115.43 |
| 83883 | 14 | 12 | $112.15 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,141 | 1,037 | $110.09 |
| 84153 | 14 | 12 | $107.79 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,214 | 1,109 | $91.95 |
| 82043 | 32 | 29 | $76.94 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 166 | 131 | $74.07 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 596 | 510 | $58.92 |
| 73140 | 12 | 12 | $54.66 | |
| 84480 | 18 | 14 | $54.55 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 14 | 13 | $52.07 |
| 82785 | 12 | 12 | $46.66 | |
| J7050 | Infusion, normal saline solution, 250 cc | 419 | 307 | $45.50 |
| 99152 | 69 | 67 | $40.72 | |
| 84165 | 17 | 12 | $40.14 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 543 | 408 | $37.07 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 405 | 385 | $32.76 |
| 87340 | 13 | 12 | $32.18 | |
| 87147 | 60 | 58 | $29.18 | |
| J7510 | Prednisolone oral, per 5 mg | 299 | 292 | $24.81 |
| 82140 | 44 | 42 | $21.08 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 32 | 12 | $13.14 |
| J1956 | Injection, levofloxacin, 250 mg | 100 | 86 | $12.22 |
| J0456 | Injection, azithromycin, 500 mg | 52 | 38 | $7.90 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 94 | 90 | $6.35 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 41 | 40 | $4.16 |
| J1940 | Injection, furosemide, up to 20 mg | 45 | 38 | $3.54 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | 24 | $0.92 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 28 | 25 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 39 | 32 | $0.00 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 13 | 13 | $0.00 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 52 | 51 | $0.00 |
| C1758 | Catheter, ureteral | 14 | 13 | $0.00 |
| 82010 | 43 | 39 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 30 | 25 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 13 | 13 | $0.00 |
| 86308 | 13 | 12 | $0.00 | |
| J3490 | Unclassified drugs | 62 | 25 | $0.00 |